OUR COMPANY

Handa Pharma, Inc. (“Handa”) is a specialty pharmaceutical company in the San Francisco Bay area. Our mission is to leverage our entrepreneurial spirit and technical expertise to develop and commercialize high-quality prescription medications that address significant unmet patient needs.

Handa’s executive and scientific leadership team has a proven track record of building effective teams, high-quality product portfolios and successful pharmaceutical businesses. Our business model includes managing all aspects of the product development process through the submission of drug applications to the United States Food and Drug Administration (FDA).

Handa develops and commercializes prescription medications through its four wholly-owned subsidiaries:

  • Handa Pharmaceuticals, LLC (focus on generics)
  • Handa Neuroscience, LLC (owner of TASCENSO ODT)
  • Handa Oncology, LLC (focus on oncology drugs)
  • Handa Therapeutics, LLC (owner of PHYRAGOTM)

Our parent company, Handa Pharmaceuticals, Inc., was established in Taiwan in 2014.

FOCUSING

Focusing on our core competencies of intellectual property expertise and problem-solving

SPECIALIZING

Specializing in the development of innovative brands and high-barrier generics

BECOMING

Handa Pharma is becoming a global specialty pharmaceutical company